Cargando…

Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure

Elevated fibroblast growth factor 23 (FGF23) levels are associated with adverse outcome in populations with cardiovascular disease and chronic kidney failure. It is unclear if FGF23 has significance in prognosis estimation in patients with acute heart failure (HF) when compared to traditional risk e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cornelissen, Anne, Florescu, Roberta, Kneizeh, Kinan, Cornelissen, Christian, Brandenburg, Vincent, Liehn, Elisa, Schuh, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324826/ https://www.ncbi.nlm.nih.gov/pubmed/34330955 http://dx.doi.org/10.1038/s41598-021-94780-7

Ejemplares similares

Fibroblast Growth Factor 23 and Outcome Prediction in Patients with Acute Myocardial Infarction
por: Cornelissen, Anne, et al.
Publicado: (2022)

The Role of Vitamin D(3) as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure
por: Thiele, Kirsten, et al.
Publicado: (2022)

Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction
por: Vergaro, Giuseppe, et al.
Publicado: (2023)

Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome
por: Florescu, Roberta, et al.
Publicado: (2022)

Plasma intact fibroblast growth factor 23 levels in women with anorexia nervosa
por: Otani, Makoto, et al.
Publicado: (2008)

Serum intact fibroblast growth factor 23 in healthy paediatric population
por: Stanczyk, Malgorzata, et al.
Publicado: (2021)

Apolipoprotein E deficient rats generated via zinc-finger nucleases exhibit pronounced in-stent restenosis
por: Cornelissen, Anne, et al.
Publicado: (2019)

Intact fibroblast growth factor 23 and fragments in plasma from Gambian children
por: Braithwaite, V., et al.
Publicado: (2012)

Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children
por: Braithwaite, Vickie, et al.
Publicado: (2013)

High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis
por: Fang, Yu-Wei, et al.
Publicado: (2023)

Lack of PTEN in osteocytes increases circulating phosphate concentrations by decreasing intact fibroblast growth factor 23 levels
por: Kawai, Masanobu, et al.
Publicado: (2020)

Fibroblast growth factor 23 in children with or without heart failure: a prospective study
por: Elzayat, Rania Salah, et al.
Publicado: (2023)

Plasma intact fibroblast growth factor 23 levels in women with bulimia nervosa: A cross-sectional pilot study
por: Otani, Makoto, et al.
Publicado: (2011)

Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients
por: Lee, Wen-Teng, et al.
Publicado: (2023)

Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism
por: Stöhr, Robert, et al.
Publicado: (2022)

Fibroblast growth factor 21 in heart failure
por: Tucker, William, et al.
Publicado: (2022)

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction
por: Roy, Clotilde, et al.
Publicado: (2020)

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
por: Almahmoud, Mohamed Faher, et al.
Publicado: (2018)

Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery
por: Hofer, Felix, et al.
Publicado: (2023)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Fibroblast‐growth‐factor‐23 in heart failure with preserved ejection fraction: relation to exercise capacity and outcomes
por: Kanagala, Prathap, et al.
Publicado: (2020)

Direct and indirect effects of fibroblast growth factor 23 on the heart
por: Nakano, Toshiaki, et al.
Publicado: (2023)

Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling
por: Schumacher, David, et al.
Publicado: (2021)

Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
por: Lutsey, Pamela L., et al.
Publicado: (2014)

Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study
por: Leidner, Alexander S., et al.
Publicado: (2023)

Circulating fibroblast growth factor 23 levels and incident dementia: The Framingham heart study
por: McGrath, Emer R., et al.
Publicado: (2019)

Changes in Serum Intact Fibroblast Growth Factor 23 Concentrations From Midlife to Late Life and Their Predictors in the Community: The ARIC Study
por: Ishigami, Junichi, et al.
Publicado: (2022)

FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018)

Apolipoprotein E4 Is Associated with Right Ventricular Dysfunction in Dilated Cardiomyopathy—An Animal and In-Human Comparative Study
por: Diaconu, Rodica, et al.
Publicado: (2021)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Corrigendum: FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
por: Stöhr, Robert, et al.
Publicado: (2018)

Epoetin Beta and C‐Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
por: Eisenga, Michele F., et al.
Publicado: (2019)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Oral iron supplementation with sodium ferrous citrate reduces the serum intact and c‐terminal fibroblast growth factor 23 levels of maintenance haemodialysis patients
por: Yamashita, Kazuomi, et al.
Publicado: (2017)

Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease
por: Raji, Yemi R, et al.
Publicado: (2022)

Intact Fibroblast Growth Factor 23 Regulates Chronic Kidney Disease–Induced Myocardial Fibrosis by Activating the Sonic Hedgehog Signaling Pathway
por: Li, Lanlan, et al.
Publicado: (2022)

Repetitive transplantation of different cell types sequentially improves heart function after infarction
por: Alexander, Schuh, et al.
Publicado: (2012)

The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia
por: Czaya, Brian, et al.
Publicado: (2019)

Anti-inflammatory Gold-Induced Autologous Cytokines treatment triggers heart failure after myocardial infarction
por: Cordes, Franziska, et al.
Publicado: (2017)

High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in Regular Hemodialysis Patients
por: Kandarini, Yenny, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rv7kb6h9ubvnlioi2foemeqjmm